Babak Benjamin Navi   Associate Professor of Neurology

  • +1 212 746 0225

Babak Navi, MD, MS, is a native New Yorker who received his medical degree from New York University, where he graduated with honors (Alpha Omega Alpha Society). He completed a residency in neurology at the Weill Cornell Medical Center and served as the Chief Resident in his final year. He then completed a two-year fellowship in vascular neurology at the University of California, San Francisco, where he also became certified in comprehensive neurosonology. In 2011, Dr. Navi returned to New York to join the neurology faculty at Weill Cornell. He is currently the Medical Director of the Cornell Stroke Center and an Associate Professor of Neurology and Neuroscience.

Dr. Navi is an expert on the relationship between stroke and cancer. He has published numerous studies on this topic, and is the co-principal investigator of the first randomized trial to compare different blood thinners for patients with cancer and stroke. Dr. Navi also has conducted research studies on cryptogenic stroke, postpartum stroke, cerebrovascular presentations of dizziness, and the prognostic abilities of neurologists. His work has been published in high impact peer-reviewed journals, including the New England Journal of MedicineJAMA, JACC, Annals of NeurologyNeurology, JAMA NeurologyCritical Care MedicineStroke, and Annals of Emergency Medicine. In addition, he was awarded an NIH KL2 grant in 2012 from the Cornell CTSC and an NIH K23 grant in 2015. Dr. Navi is an Associate Editor for the journal Neurohospitalist, and is the Cornell site principal investigator for the NIH-funded POINT trial. He also holds the Florence Gould Endowment for Discovery in Stroke and is the Associate Director of the Clinical and Translational Neuroscience Unit (CTNU) within the Cornell Brain and Mind Research Institute. 


Sort by

Selected publications


Sort by

Grants awarded

  • Cancer And Risk Of Ischemic Stroke  awarded by National Institute of Neurological Disorders & Stroke Principal Investigator 2015 - 2020
  • Clinical and Translational Science Center (KL2) - Career Award  awarded by National Center for Advancing Translational Sciences Key Personnel 2012 - 2017
  • MISTIE III: A Phase III, Randomized, Open-Label, 500-Subject Clinical Trial of Minimally Invasive Surgery Plus rt-PA  awarded by National Institute of Neurological Disorders & Stroke Key Personnel 2013 -
  • POINT- Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial  awarded by National Institute of Neurological Disorders & Stroke Principal Investigator Subaward 2013 - 2017



Primary Email



Primary Affiliation

  • Weill Cornell Medical College, Cornell University